ImmunityBio, Inc.
IBRX
$7.76
-$0.30-3.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 357.37M | 380.88M | 242.82M | 257.81M | 153.66M |
| Total Receivables | 53.50M | 43.27M | 42.62M | 33.72M | 22.33M |
| Inventory | 1.94M | 547.00K | 910.00K | 6.70M | 6.64M |
| Prepaid Expenses | 26.17M | 18.92M | 16.85M | 19.02M | 15.85M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 9.33M | 11.68M | 12.25M | 9.65M |
| Total Current Assets | 438.98M | 452.95M | 314.88M | 329.50M | 208.13M |
|
|
|||||
| Total Current Assets | 438.98M | 452.95M | 314.88M | 329.50M | 208.13M |
| Net Property, Plant & Equipment | 145.69M | 146.08M | 147.55M | 163.08M | 168.03M |
| Long-term Investments | -- | 910.00K | 910.00K | 910.00K | 910.00K |
| Goodwill | -- | 910.00K | 910.00K | 910.00K | 910.00K |
| Total Other Intangibles | 11.84M | 11.98M | 13.04M | 13.57M | 14.07M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 32.00M | 34.72M | 11.32M | 11.24M | 10.24M |
| Total Assets | 628.50M | 646.64M | 501.90M | 518.99M | 402.08M |
|
|
|||||
| Total Accounts Payable | 12.00M | 11.19M | 6.98M | 5.77M | 7.42M |
| Total Accrued Expenses | 56.02M | 44.87M | 42.01M | 39.33M | 33.89M |
| Short-term Debt | -- | 884.00K | 1.75M | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.56M | 7.68M | 7.59M | 7.37M | 7.44M |
| Total Finance Division Other Current Liabilities | 1.15M | 3.33M | 3.42M | 4.67M | 1.90M |
| Total Other Current Liabilities | 1.15M | 3.33M | 3.42M | 4.67M | 1.90M |
| Total Current Liabilities | 76.73M | 67.95M | 61.75M | 57.13M | 50.64M |
|
|
|||||
| Total Current Liabilities | 76.73M | 67.95M | 61.75M | 57.13M | 50.64M |
| Long-Term Debt | 1.19B | 1.08B | 801.71M | 816.95M | 799.13M |
| Short-term Debt | -- | 884.00K | 1.75M | -- | -- |
| Capital Leases | 31.40M | 33.36M | 33.67M | 34.37M | 36.09M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 376.70M | 331.77M | 104.34M | 133.94M | 86.03M |
| Total Liabilities | 1.67B | 1.52B | 1.00B | 1.04B | 971.90M |
|
|
|||||
| Common Stock & APIC | 3.52B | 3.46B | 3.20B | 3.14B | 3.01B |
| Retained Earnings | -4.59B | -4.36B | -3.73B | -3.66B | -3.60B |
| Treasury Stock & Other | 27.28M | 27.45M | 28.96M | 5.00M | 12.57M |
| Total Common Equity | -1.05B | -870.01M | -500.47M | -524.32M | -570.75M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.05B | -870.01M | -500.47M | -524.32M | -570.75M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 868.00K | 880.00K | 895.00K | 909.00K | 930.00K |
| Total Equity | -1.05B | -869.13M | -499.57M | -523.41M | -569.82M |
|
|
|||||